Evidence map›Paper›PMID 33123349›Full record

ArticleF1000Research2020

Emily Mantlo, Tanya Rhodes, Jenny Boutros, Laura Patterson-Fortin, Alex Evans, Slobodan Paessler

Abstract read
In one paragraph

Article in F1000Research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Disinfection methods against SARS-CoV-2: a systematic review.The Journal of hospital infection · 2022
    Pooled it
  2. Insight into the role of copper-based materials against the coronaviruses MHV-3, a model for SARS-CoV-2, during the COVID-19 pandemic.Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2024
    Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Antimicrobial resistance: A challenge awaiting the post-COVID-19 era.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2021
    Article
  8. Review
  9. Article
  10. Article
  11. F1000Research · 2020
    Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Emily MantloUniversity of Texas Medical Branch at Galveston, Galveston, Texas, USA.
Tanya RhodesClyra Medical Technologies, Inc., Tampa, Florida, USA.
Jenny BoutrosBioLargo Water, Inc., Edmonton, Alberta, Canada.
Laura Patterson-FortinBioLargo Water, Inc., Edmonton, Alberta, Canada.
Alex EvansBioLargo, Inc., Westminster, California, USA.ORCID 0000-0003-4319-1743
Slobodan PaesslerUniversity of Texas Medical Branch at Galveston, Galveston, Texas, USA.

Funding

West African Center for Emerging Infectious DiseasesU01AI151801 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI Robert W Cross, Scott C Weaver · 2020 to 2026
$10.1M
Biodefense Training ProgramT32AI060549 · NIAID · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI ASHOK K CHOPRA, Janice J Endsley · 2004 to 2026
$3.0M
NIAID NIH HHS T32 AI060549NIAID NIH HHS U01 AI151801
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

BetacoronavirusCopperDisinfectantsIodineVirus InactivationCoronavirus InfectionsCOVID-19HumansPandemicsPneumonia, ViralSARS-CoV-2CopperDisinfectantsIodineCOVIDdecontaminationdisinfectioniodinePPEvirus

Identifiers

PMID33123349
PMCPMC7569480

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.